Product Description
CJC 1295 with DAC Peptide Magnus Pharmaceuticals
The CJC 1295 with DAC Peptide Magnus Pharmaceuticals is a so-called GHRH peptide. That is, It ensures an increased release of body growth hormone. As well as an increase in the body‘s concentration of IGF-1. These peptides are well suited to build more muscle mass and also to reduce the body fat percentage over the long term.
CJC 1295 with DAC Peptide Magnus Pharmaceuticals has a very long half-life of several days. It significantly increases the release of growth hormone by the adenohypophysis.
CJC 1295 with DAC Peptide Magnus Pharmaceuticals is, so to speak, the „extended release“ variant of a GHRH peptide. In the long term, it supports the body‘s secretion of growth hormone at a higher level. For example, for a generally better well-being.
The Benefits of CJC 1295 with DAC Peptide Magnus Pharmaceuticals:
- Increased sexual drive CJC 1295 with DAC Peptide Magnus Pharmaceuticals
- Improvement of the immune system by CJC 1295 with DAC Peptide Magnus Pharmaceuticals application
- CJC 1295 with DAC Peptide Magnus Pharmaceuticals radically increases the IGF1 production
- Improvement of bone density by CJC 1295 with DAC Peptide Magnus Pharmaceuticals
- CJC 1295 with DAC Peptide Magnus Pharmaceuticals increases protein synthesis
- Improvement of organ functions by CJC 1295 with DAC Peptide Magnus Pharmaceuticals
- Reduction of abdominal fat by CJC 1295 with DAC Peptide Magnus Pharmaceuticals Cure
- Improves energy and vitality with CJC 1295 with DAC Peptide Magnus Pharmaceuticals
- CJC 1295 with DAC Peptide Magnus Pharmaceuticals improves the skin tone
- Improves endurance with CJC 1295 with DAC Peptide Magnus Pharmaceuticals
- Accelerates wound healing by CJC 1295 with DAC Peptide Magnus Pharmaceuticals
- CJC 1295 with DAC Peptide Magnus Pharmaceuticals strengthens the heart
- Increases sleep quality CJC 1295 with DAC Peptide Magnus Pharmaceuticals
- Positive effects on the eyes CJC 1295 with DAC Peptide Magnus Pharmaceuticals
CJC 1295 with DAC Peptide Magnus Pharmaceuticals is structurally closely related to the body-specific GHRH peptide hormone.
However, since GHRH itself is quite expensive and expensive to produce and has only an extremely short time of action, it is generally not used by users, for example bodybuilders or other athletes. The American / Canadian biotechnology company ConjuChem therefore developed a modified new peptide, comprising the first 29 amino acids of GHRH, starting from the structure of the natural, 44 amino acid GHRHs. In addition, a so-called DAC ( „drug affinity complex“) based on the amino acid lysine was added to the new peptide in a method developed by ConjuChem.
This DAC prevents the early degradation (degradation) of the peptide and increases the half-life by drastically up to 7 days by the peptide selectively binding to freely circulating albumin during the so-called bioconjugation after injection. Due to this, the concentration of CJC 1295 with DAC Peptide Magnus Pharmaceuticals remains at a uniform level after injection, which gradually decreases over several days.
CJC 1295 with DAC Peptide Magnus Pharmaceuticals strengthens the body‘s secretion of growth hormones:
The acute delivery of the peptide itself does not elicit an immediate growth hormone pulse in the adenohypophysis. Instead, the peptide continues to increase the amplitude of naturally-distributed waves of growth hormone secretion throughout the day. Furthermore, CJC 1295 with DAC Peptide Magnus Pharmaceuticals also increases the production of IGF-1 in the liver. This results in further anabolic (and thus desirable for athletes) desirable effects.
While normally an increase in growth hormone secretion also provides an increase in the concentration of the hormone prolactin, it remains within the scope of the supply of CJC 1295 with DAC Peptide Magnus Pharmaceuticals. High prolactin values reduce libido in men and can lead to impotence as well as mental problems (especially impotence).
Since CJC 1295 with DAC Peptide Magnus Pharmaceuticals improves the secretion of growth hormone as well as prevents prolactin concentration increase, the protein biosynthesis in the body also proceeds more efficiently. This also promotes the development of new muscle masses. Furthermore, CJC 1295 with DAC Peptide Magnus Pharmaceuticals can also trigger the breakdown (lipolysis) of adipose tissue by its effect on growth hormone secretion. Increase bone density or promote cell renewal in damaged or aged tissue.
When, how and for what is CJC 1295 with DAC Peptide Magnus Pharmaceuticals used and dosed?
As described above, CJC 1295 with DAC Peptide Magnus Pharmaceuticals ensures that the adenohypophysis releases larger amounts of growth hormone over a longer period of time.
Therefore, the peptide is particularly suitable for users who are not able to inject frequently and for users. Want to find a basic way to increase their growth hormone concentration. Instead of reaching a point-by-point maximization of growth hormone secretion.
In this way, the peptide provides in the background, so to speak, for the user to achieve better results in terms of muscle build-up or fat loss. If the other factors in the execution of your own training and nutritional plan are also consistent in themselves and are adhered to.
As a rule, CJC 1295 with DAC Peptide Magnus Pharmaceuticals is injected twice a week (every 3 to 4 days) with 1 mg each.
The best time for injection of CJC 1295 with DAC Peptide Magnus Pharmaceuticals is in itself before going to bed. Since the peptide, according to many reports, can also provide for a relaxing and regenerative effective sleep.
Side effects are rarely associated with the use of CJC 1295 with DAC Peptide Magnus Pharmaceuticals. There may be joint pain or slight numbness in the hands and feet.
Muscle Mass Composition Combination Mod GRF 1-29 and CJC 1295 with DAC Peptide Magnus Pharmaceuticals:
Thus, as can be seen, both CJC 1295 with DAC Peptide Magnus Pharmaceuticals and Mod GRF 1-29 are thus GHRH peptides with identical mode of action. Their difference is due to their widely differing half-life. This allows for the repeated injection of the peptide several times a day (and makes it practically necessary for meaningful results at the same time). At least 3 hours should elapse between injections.
The number of injections can be adapted to individual wishes and needs. And moves with most users between 2 and 3 times a day. Investigations have shown that a dose of 100 mcg Mod GRF 1-29 is sufficient to completely occupy the corresponding receptors in the adenohypophysis. Thus, the injection of more than 100 mcg of Mod GRF 1-29 at once results in only a slight increase in the effect of secretion of additional growth hormone.
What makes sense, however, is the combination of Mod GRF 1-29 with a GHRP peptide, e.g. GHRP-6.
There is a strong synergy between these types of peptides. While the GHRP peptide triggers a growth hormone pulse, it is amplified by Mod GRF 1-29. For example, the supply of 100 mcg of GHRP-6 and 100 mcg of Mod GRF 1-29 leads to the same secretion of growth hormone as if 300 mcg of GHRP-6 had been added. In general, the combination of Mod GRF 1-29 and a GHRP peptide makes sense for all users who want to dispense with expensive – and often fake – synthetic HGH. The use of these peptides stimulates and enhances the body‘s production of growth hormone rather than externally adding growth hormone. Because of this more natural course for the body, Mod GRF 1-29 does not necessarily have to be gecycled, but can also be used theoretically permanently.
